C. Efrata, T. (2016). R&D INTENSITY AND IPO UNDERPRICING: CASE STUDY ON PHARMACEUTICAL AND BIOTECH INDUSTRIES IN THE US. Journal of Accounting and Investment, 9(1), 1–21. Retrieved from https://journal.umy.ac.id/index.php/ai/article/view/1083